Ernexa Therapeutics Cash Flow Statement (2010-2026) | ERNAW

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-10.01M-85.99M114.52M-9.38M-3.40M-7.32M-4.45M-5.42M-4.51M-5.59M-6.14M-6.65M-5.53M-26.60M38.80M-8.20M-3.14M-1.24M-1.55M-5.51M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
1.15M1.73M1.93M1.18M0.88M0.48M0.40M0.69M0.21M0.17M0.17M0.28M0.42M0.41M0.41M0.50M0.37M0.29M-1.02M0.31M
Cash from Discontinued Operations (Quarter)
Gains from Sales and Divestitures (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M29.0029.000.00M30.0030.000.00M
Gains from Investment Securities (Quarter)
0.10M0.01M0.06M0.10M0.06M-0.00M-0.02M-1.13M1.87M0.07M-0.83M0.90M-0.00M0.13M0.01M-0.01M0.20M
Asset Writedowns and Impairment (Quarter)
0.03M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)
18.50M2.30M1.40M
Cash from Operations (Quarter)
-6.80M-6.42M-6.83M-5.43M-3.99M-6.12M-5.43M-6.05M-3.87M-5.83M-4.66M-3.75M-2.26M-6.29M-3.54M-2.06M-2.54M-1.27M-1.15M-2.30M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
2.00M
Amortizatization of Intangibles (Quarter)
0.08M0.09M0.10M0.10M0.08M0.08M0.07M0.04M0.04M0.50M0.46M0.50M0.53M0.41M0.05M0.05M0.04M0.05M0.06M0.08M
Amortization of Deferred Charges (Quarter)
0.10M0.25M0.45M0.50M0.42M4.43M
Depreciation & Amortization (CF) (Quarter)
0.04M0.03M0.02M0.04M0.07M0.04M0.02M0.02M0.02M0.02M0.02M0.04M0.04M0.04M0.02M0.02M0.02M0.02M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
-0.00M0.66M0.15M-0.14M0.23M0.03M-0.30M0.34M0.79M-1.35M-0.07M-0.12M-0.04M0.25M-0.28M-0.00M-0.00M-0.06M
Change in Account Payables (Quarter)
3.39M-0.44M-0.44M-0.44M-0.44M-0.44M-0.44M-0.44M0.23M-0.56M-0.50M
Change in Accured Expenses (Quarter)
0.98M-0.78M-0.18M-0.20M2.50M-0.92M-1.22M-1.77M1.31M0.09M-0.01M0.46M-0.24M-0.11M-0.09M-0.10M0.23M-0.29M0.18M0.76M
Change in Taxes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
22.85M-22.70M0.05M0.19M0.04M0.02M0.02M0.10M0.25M0.02M0.01M0.00M
Sales of Property, Plant and Equipment (Quarter)
-0.00M-0.15M0.10M0.15M0.00M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-0.00M-22.86M-0.15M-0.05M-0.09M-0.04M0.13M-0.02M-0.10M-0.25M-0.02M-0.01M-0.00M
Financing Activities
Other financing activities (Quarter)
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
16.50M1.41M2.25M
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
0.01M0.01M11.99M7.71M1.10M0.00M4.92M-4.90M10.48M
Dividend Payments
Dividends Paid - Common (Quarter)
0.01M0.01M0.01M
Misc.
Cash from Financing Activities (Quarter)
48.56M3.50M-0.42M11.99M-0.01M0.01M7.59M0.31M8.54M7.70M1.39M-0.02M3.89M1.01M2.25M4.93M0.03M9.56M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
41.76M-25.78M-7.40M6.51M-4.09M-6.15M2.29M-6.05M-3.56M2.71M3.02M-2.46M-2.53M-2.42M-2.54M0.19M2.40M-1.27M-1.16M7.29M
Free Cash Flow (Quarter)
-6.80M-29.28M15.87M-5.48M-4.18M-6.16M-5.46M-6.05M-3.87M-5.83M-4.68M-3.85M-2.51M-6.30M-3.54M-2.06M-2.54M-1.27M-1.16M-2.30M
Net Cash Flow (Quarter)
41.76M-25.78M-7.40M6.51M-4.09M-6.15M2.29M-6.05M-3.56M2.71M3.02M-2.46M-2.53M-2.42M-2.54M0.19M2.39M-1.24M-1.16M7.26M